ART Present at the Annual Conference of The Academy of Molecular Imaging in Orlando, Florida.MONTREAL -- ART Advanced Research Technologies Inc. ("ART") (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension :ARA Ara or Arrah (both: ŭ`rə), city (1991 pop. 157,082), Bihar state, NE India, on the Son Canal. A major road and rail junction, it is the administrative center for a district that produces grain, sugarcane, and oilseed. ) Scientific presentation by University of Wisconsin team to feature ART's Fenestra(TM) imaging contrast agents for MicroCT ART Advanced Research Technologies Inc. ("ART"), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce its participation at the annual conference of the AMI, being held at the Gaylord Palms Resort and Convention Center in Orlando, Florida The city of Orlando is a major city in central Florida and is the county seat of Orange County, Florida. According to the 2000 census, the city population was 185,951. A 2006 U.S. , from March 25 to 29, 2006. ART's Fenestra(TM) biomarker technology will be included in the "Meet the Authors" poster session A poster session is the juried presentation of research information by representatives of several research teams at a congress or conference with an academic or professional focus. These are particularly prominent at scientific conferences such as medical congresses. being held today, March 27, 2006, between 5:30 and 7 p.m., featuring five research teams headed by Dr. Jamey P. Weichert, Associate Professor in Radiology at the University of Wisconsin, presenting scientific posters. The following posters will be presented by Dr. Giangthy N. Ton, post-doctoral fellow at the University of Wisconsin: - Poster #244: "Effects of Administration Routes on MicroCT Imaging Characteristics of a Long-Acting Vascular Contrast Agent in a Murine Model", Giangthy N. Ton(1,2), Douglas A. Bakan(2), William C. Dow(2), Nicole P.H. Chia(1), Jamey P. Weichert(1), (1)University of Wisconsin, USA, (2)Alerion Biomedical Inc., USA. - Poster #283: "In vivo MicroCT Imaging Characteristics of a Long- Acting Blood Pool Agent in Normal and Tumor-Bearing Mice", Giangthy N. Ton(1,2), Ben Durkee(1), Jamey P. Weichert(1), (1)University of Wisconsin, USA, (2)Alerion Biomedical Inc., USA. - Poster #241: "Effects of Administration Dose, Species and Strain Variations on MicroCT Imaging Characteristics of a Long-Acting Blood-Pool Agent in Normal Rodents", Giangthy N. Ton(1,2), Cindy Burrascano(2), William C. Dow(2), Douglas A. Bakan(2), Jamey P. Weichert(1), (1)University of Wisconsin, USA, (2)Alerion Biomedical Inc., USA. - Poster #242: "Effects of Dose, Sex, and Species Variations on Imaging Efficacy of a Hepatocyte-Selective Contrast Agent in Normal Rodents", Giangthy N. Ton(1,2), Marco Melchior(2), William Dow(2), Douglas Bakan(2), Jamey P. Weichert(1), (1)University of Wisconsin, USA, (2)Alerion Biomedical Inc., USA. - Poster #243: "MicroCT Evaluations of a Long-Lasting Blood Pool and Hepatobiliary Contrast Agents Following Multiple Intravenous Injections in Normal Mouse Models", Giangthy N. Ton(1,2), Nicole P.H. Chia(1), William C. Dow(2), Douglas A. Bakan(2), Jamey P. Weichert(1), (1)University of Wisconsin, USA, (2)Alerion Biomedical Inc., USA. "These research results illustrate capabilities for MicroCT evaluations using Fenestra VC and Fenestra LC," said Micheline Bouchard, ART's President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "We are confident that as more and more researchers work with these long-lasting blood pool and hepatobiliary contrast agents in rodent rodent, member of the mammalian order Rodentia, characterized by front teeth adapted for gnawing and cheek teeth adapted for chewing. The Rodentia is by far the largest mammalian order; nearly half of all mammal species are rodents. models, the scientific data generated will establish the wide range of imaging applications for this product line," added Ms. Bouchard. In addition, ART is taking part in the event as an exhibitor in the GE Healthcare GE Healthcare is a $18 billion (USD) unit of General Electric (GE). It employs more than 46,000 people worldwide and is headquartered in Chalfont St. Giles, Buckinghamshire, United Kingdom. GE Healthcare is the first GE business segment headquartered outside the United States. booth (#506), and is presenting eXplore Optix(TM), a pre-clinical optical molecular imager designed to provide in vivo in vivo /in vi·vo/ (ve´vo) [L.] within the living body. in vi·vo adj. Within a living organism. in vivo adv. biodistribution and pharmacokinetics data, at the booth located in Exhibit Hall 'F' of the Gaylord Palms Resort and Convention Center. About ART ART Advanced Research Technologies Inc. is a leader in optical molecular imaging products for the healthcare and pharmaceutical industries. ART has developed products in medical imaging, medical diagnostics, disease research, and drug discovery with the goal of bringing new and better treatments to patients faster.eXplore Optix(TM), an optical molecular imaging device designed for monitoring physiological changes in living systems at the preclinical study phases of new drugs, is distributed by GE Healthcare and is used by industry and academic leaders worldwide.SoftScan(R), an opticalmedical imaging device, is designed to improve the diagnosis and treatment of breast cancer.ART is commercializing these products in a global strategic alliance with GE Healthcare, a world leader in mammography mammography, diagnostic procedure that uses low-dose X rays to detect abnormalities in the breasts. The early diagnosis of breast cancer made possible by the routine use of mammography for screening women increases a woman's treatment alternatives and improves her and imaging. Finally, the Fenestra(TM) line of molecular imaging contrast products provide image enhancement See image editing. for a wide range of preclinical Micro CT applications allowing scientists to see greater detail in their imaging studies, with potential use with other major imaging modalities Modalities The factors and circumstances that cause a patient's symptoms to improve or worsen, including weather, time of day, effects of food, and similar factors. .ART's shares are listed on the TSX under the ticker symbol Ticker Symbol An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors ARA. For more information on ART, visit our website at www.art.ca . This press release may contain forward-looking statements subject to risks and uncertainties that would cause actual events to differ materially from expectations. These risks and uncertainties are described in ART Advanced Research Technologies Inc.'s regulatory filings with Canadian Securities Commissions and the Securities and Exchange Commission in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . ART Advanced Research Technologies Inc. (TSX:ARA) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion